Kesselheim AS - Search Results

1

Vaccine Pipeline Has Grown During The Past Two Decades With More Early-Stage Trials From Small And Medium-Size Companies.

Hwang TJ, Kesselheim AS. Hwang TJ, et al. Among authors: kesselheim as. Health Aff (Millwood). 2016 Feb;35(2):219-26. doi: 10.1377/hlthaff.2015.1073. Health Aff (Millwood). 2016. PMID: 26858373

2

Biomedical patents and the public's health: is there a role for eminent domain?

Kesselheim AS, Avorn J. Kesselheim AS, et al. JAMA. 2006 Jan 25;295(4):434-7. doi: 10.1001/jama.295.4.434. JAMA. 2006. PMID: 16434634 No abstract available.

3

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Jul-Aug;25(4):1095-102. doi: 10.1377/hlthaff.25.4.1095. Health Aff (Millwood). 2006. PMID: 16835191

4

Extensions of intellectual property rights and delayed adoption of generic drugs: effects on medicaid spending.

Kesselheim AS, Fischer MA, Avorn J. Kesselheim AS, et al. Health Aff (Millwood). 2006 Nov-Dec;25(6):1637-47. doi: 10.1377/hlthaff.25.6.1637. Health Aff (Millwood). 2006. PMID: 17102189

5

Confidentiality laws and secrecy in medical research: improving public access to data on drug safety.

Kesselheim AS, Mello MM. Kesselheim AS, et al. Health Aff (Millwood). 2007 Mar-Apr;26(2):483-91. doi: 10.1377/hlthaff.26.2.483. Health Aff (Millwood). 2007. PMID: 17339677 Review.

6

Market-based licensing for HPV vaccines in developing countries.

Outterson K, Kesselheim AS. Outterson K, et al. Among authors: kesselheim as. Health Aff (Millwood). 2008 Jan-Feb;27(1):130-9. doi: 10.1377/hlthaff.27.1.130. Health Aff (Millwood). 2008. PMID: 18180488

7

How Medicare could get better prices on prescription drugs.

Outterson K, Kesselheim AS. Outterson K, et al. Among authors: kesselheim as. Health Aff (Millwood). 2009 Sep-Oct;28(5):w832-41. doi: 10.1377/hlthaff.28.5.w832. Epub 2009 Jul 30. Health Aff (Millwood). 2009. PMID: 19643778

8

Managing financial and nonfinancial conflicts of interest in healthcare delivery.

Kesselheim AS, Maisel WH. Kesselheim AS, et al. Am J Ther. 2010 Jul-Aug;17(4):440-3. doi: 10.1097/MJT.0b013e3181d01cae. Am J Ther. 2010. PMID: 20215960

9

State generic substitution laws can lower drug outlays under Medicaid.

Shrank WH, Choudhry NK, Agnew-Blais J, Federman AD, Liberman JN, Liu J, Kesselheim AS, Brookhart MA, Fischer MA. Shrank WH, et al. Among authors: kesselheim as. Health Aff (Millwood). 2010 Jul;29(7):1383-90. doi: 10.1377/hlthaff.2009.0424. Health Aff (Millwood). 2010. PMID: 20606192 Free PMC article.

10

Fighting antibiotic resistance: marrying new financial incentives to meeting public health goals.

Kesselheim AS, Outterson K. Kesselheim AS, et al. Health Aff (Millwood). 2010 Sep;29(9):1689-96. doi: 10.1377/hlthaff.2009.0439. Health Aff (Millwood). 2010. PMID: 20820028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results